232 related articles for article (PubMed ID: 16644048)
1. Identification and functional significance of polymorphisms in the mu-opioid receptor gene (Oprm) promoter of C57BL/6 and DBA/2 mice.
Doyle GA; Sheng XR; Schwebel CL; Ferraro TN; Berrettini WH; Buono RJ
Neurosci Res; 2006 Jul; 55(3):244-54. PubMed ID: 16644048
[TBL] [Abstract][Full Text] [Related]
2. Fine mapping of a major QTL influencing morphine preference in C57BL/6 and DBA/2 mice using congenic strains.
Doyle GA; Furlong PJ; Schwebel CL; Smith GG; Lohoff FW; Buono RJ; Berrettini WH; Ferraro TN
Neuropsychopharmacology; 2008 Nov; 33(12):2801-9. PubMed ID: 18288093
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of mu-opioid receptor gene in CXBK and B6 mice by Sp1.
Lee PW; Wu S; Lee YM
Mol Pharmacol; 2004 Dec; 66(6):1580-4. PubMed ID: 15562256
[TBL] [Abstract][Full Text] [Related]
4. Identification of three mouse mu-opioid receptor (MOR) gene (Oprm1) splice variants containing a newly identified alternatively spliced exon.
Doyle GA; Rebecca Sheng X; Lin SS; Press DM; Grice DE; Buono RJ; Ferraro TN; Berrettini WH
Gene; 2007 Feb; 388(1-2):135-47. PubMed ID: 17156941
[TBL] [Abstract][Full Text] [Related]
5. Quantitative trait loci mapping of three loci controlling morphine preference using inbred mouse strains.
Berrettini WH; Ferraro TN; Alexander RC; Buchberg AM; Vogel WH
Nat Genet; 1994 May; 7(1):54-8. PubMed ID: 8075641
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation of mouse mu opioid receptor gene: Sp3 isoforms (M1, M2) function as repressors in neuronal cells to regulate the mu opioid receptor gene.
Choi HS; Hwang CK; Kim CS; Song KY; Law PY; Wei LN; Loh HH
Mol Pharmacol; 2005 May; 67(5):1674-83. PubMed ID: 15703380
[TBL] [Abstract][Full Text] [Related]
7. Intracisternal A-particle element in the 3' noncoding region of the mu-opioid receptor gene in CXBK mice: a new genetic mechanism underlying differences in opioid sensitivity.
Han W; Kasai S; Hata H; Takahashi T; Takamatsu Y; Yamamoto H; Uhl GR; Sora I; Ikeda K
Pharmacogenet Genomics; 2006 Jun; 16(6):451-60. PubMed ID: 16708053
[TBL] [Abstract][Full Text] [Related]
8. Genomic variations and transcriptional regulation of the human mu-opioid receptor gene.
Bayerer B; Stamer U; Hoeft A; Stüber F
Eur J Pain; 2007 May; 11(4):421-7. PubMed ID: 16843022
[TBL] [Abstract][Full Text] [Related]
9. Confirmation of a major QTL influencing oral morphine intake in C57 and DBA mice using reciprocal congenic strains.
Ferraro TN; Golden GT; Smith GG; Martin JF; Schwebel CL; Doyle GA; Buono RJ; Berrettini WH
Neuropsychopharmacology; 2005 Apr; 30(4):742-6. PubMed ID: 15508023
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis underlying the poly C binding protein 1 as a regulator of the proximal promoter of mouse mu-opioid receptor gene.
Malik AK; Flock KE; Godavarthi CL; Loh HH; Ko JL
Brain Res; 2006 Sep; 1112(1):33-45. PubMed ID: 16904079
[TBL] [Abstract][Full Text] [Related]
11. The angiotensin II receptor (Agtr1a): functional regulatory polymorphisms in a locus genetically linked to blood pressure variation in the mouse.
Wong C; Mahapatra NR; Chitbangonsyn S; Mahboubi P; Mahata M; Mahata SK; O'Connor DT
Physiol Genomics; 2003 Jun; 14(1):83-93. PubMed ID: 12697907
[TBL] [Abstract][Full Text] [Related]
12. Gene expression profiling in the striatum of inbred mouse strains with distinct opioid-related phenotypes.
Korostynski M; Kaminska-Chowaniec D; Piechota M; Przewlocki R
BMC Genomics; 2006 Jun; 7():146. PubMed ID: 16772024
[TBL] [Abstract][Full Text] [Related]
13. Poly(C) binding protein family is a transcription factor in mu-opioid receptor gene expression.
Kim SS; Pandey KK; Choi HS; Kim SY; Law PY; Wei LN; Loh HH
Mol Pharmacol; 2005 Sep; 68(3):729-36. PubMed ID: 15933215
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
[TBL] [Abstract][Full Text] [Related]
15. Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.
Maloney B; Ge YW; Alley GM; Lahiri DK
J Neurochem; 2007 Nov; 103(3):1237-57. PubMed ID: 17854398
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and functional analysis of the rat mu opioid receptor gene promoter.
Kraus J; Horn G; Zimprich A; Simon T; Mayer P; Höllt V
Biochem Biophys Res Commun; 1995 Oct; 215(2):591-7. PubMed ID: 7487996
[TBL] [Abstract][Full Text] [Related]
17. SNPs upstream of the minimal promoter control IL-2 expression and are candidates for the autoimmune disease-susceptibility locus Aod2/Idd3/Eae3.
del Rio R; Noubade R; Subramanian M; Saligrama N; Diehl S; Rincon M; Teuscher C
Genes Immun; 2008 Mar; 9(2):115-21. PubMed ID: 18200031
[TBL] [Abstract][Full Text] [Related]
18. A major species of mouse mu-opioid receptor mRNA and its promoter-dependent functional polyadenylation signal.
Wu Q; Hwang CK; Yao S; Law PY; Loh HH; Wei LN
Mol Pharmacol; 2005 Aug; 68(2):279-85. PubMed ID: 15879516
[TBL] [Abstract][Full Text] [Related]
19. Negative and positive effects of an IAP-LTR on nearby Pcdaalpha gene expression in the central nervous system and neuroblastoma cell lines.
Sugino H; Toyama T; Taguchi Y; Esumi S; Miyazaki M; Yagi T
Gene; 2004 Aug; 337():91-103. PubMed ID: 15276205
[TBL] [Abstract][Full Text] [Related]
20. Role of potassium channel gene Kcnj10 in ethanol preference in C57bl/6J and DBA/2J mice.
Zou SB; Weng J; Symons MN; Singh SM
Alcohol Clin Exp Res; 2009 Mar; 33(3):394-9. PubMed ID: 19053975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
